Kangping Technology (Suzhou) Co., Ltd.

SZSE:300907 Stok Raporu

Piyasa değeri: CN¥2.0b

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Kangping Technology (Suzhou) Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Kangping Technology (Suzhou) has a total shareholder equity of CN¥763.0M and total debt of CN¥199.3M, which brings its debt-to-equity ratio to 26.1%. Its total assets and total liabilities are CN¥1.3B and CN¥554.3M respectively. Kangping Technology (Suzhou)'s EBIT is CN¥71.8M making its interest coverage ratio -125.8. It has cash and short-term investments of CN¥323.7M.

Anahtar bilgiler

26.1%

Borç/özkaynak oranı

CN¥199.27m

Borç

Faiz karşılama oranı-125.8x
NakitCN¥323.69m
EşitlikCN¥763.02m
Toplam yükümlülüklerCN¥554.28m
Toplam varlıklarCN¥1.32b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Kangping Technology (Suzhou) (SZSE:300907) Is Increasing Its Dividend To CN¥0.50

May 27
Kangping Technology (Suzhou) (SZSE:300907) Is Increasing Its Dividend To CN¥0.50

Kangping Technology (Suzhou)'s (SZSE:300907) Solid Earnings Have Been Accounted For Conservatively

Apr 05
Kangping Technology (Suzhou)'s (SZSE:300907) Solid Earnings Have Been Accounted For Conservatively

Kangping Technology (Suzhou) Co., Ltd.'s (SZSE:300907) Shares Climb 29% But Its Business Is Yet to Catch Up

Mar 18
Kangping Technology (Suzhou) Co., Ltd.'s (SZSE:300907) Shares Climb 29% But Its Business Is Yet to Catch Up

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 300907's short term assets (CN¥911.4M) exceed its short term liabilities (CN¥543.2M).

Uzun Vadeli Yükümlülükler: 300907's short term assets (CN¥911.4M) exceed its long term liabilities (CN¥11.0M).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 300907 has more cash than its total debt.

Borcun Azaltılması: 300907's debt to equity ratio has increased from 5.2% to 26.1% over the past 5 years.

Borç Kapsamı: 300907's debt is well covered by operating cash flow (87%).

Faiz Kapsamı: 300907 earns more interest than it pays, so coverage of interest payments is not a concern.


Bilanço


Sağlıklı şirketleri keşfedin